Org.nr 991 036 393 2018 → 2019 Year-over-year analysis

PCI BIOTECH HOLDING ASA: årsregnskap 2019 vs 2018

Shrank 100% on revenue

approved 2020-05-27; registry 2020-06-13; journal 2020 419946

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2019 with 2018 for PCI BIOTECH HOLDING ASA. Revenue 9.59m NOK → 0 NOK (-100.0%). Equity 669.7k NOK → 673.5k NOK.

On the constructive side: equity strengthened; cash rose; owners injected capital. Pressures included: revenue fell.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.

Scorecard

Revenue
9.59m NOK 0 NOK
-100.0%
Operating result
n/m -4.58m NOK
—
Net result
n/m +179.0k NOK
—
Equity
669.7k NOK 673.5k NOK
+0.6%
Cash
192.4k NOK 122.79m NOK
+63730.7%
Total assets
671.8k NOK 674.6k NOK
+0.4%

What improved

  • ↑

    Equity strengthened

    Book equity 669.7k NOK → 673.5k NOK (equity ratio 99.7% → 99.8%). Calculated

  • ↑

    Cash rose

    Bank deposits 192.4k NOK → 122.79m NOK (+63730.7% YoY). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 481.5k NOK → 485.2k NOK (+3 619 NOK). Reported fact

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 9.59m NOK to 0 NOK (-100.0% YoY). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 386.3k NOK → 523.7k NOK. Reported fact